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Abstract The recent literature is replete with papers
evaluating computational tools (often those operating on
3D structures) for their performance in a certain set of
tasks. Most commonly these papers compare a number of
docking tools for their performance in cognate re-docking
(pose prediction) and/or virtual screening. Related papers
have been published on ligand-based tools: pose prediction
by conformer generators and virtual screening using a
variety of ligand-based approaches. The reliability of these
comparisons is critically affected by a number of factors
usually ignored by the authors, including bias in the data-
sets used in virtual screening, the metrics used to assess
performance in virtual screening and pose prediction and
errors in crystal structures used.
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Abbreviations
AUC Area under the curve
DPI Diffraction-coordinate precision index
RMSD Root mean square deviation
ROC Receiver operator characteristic
Introduction
Based on the large number of papers recently published, it
has become obvious that a large proportion of the
computational chemistry community, both in academia and
in industry, is very interested in evaluating and comparing
software for a number of different purposes. A large
number of publications have appeared over the last 5 years
or so that are focused on the evaluation of docking tools for
pose prediction [1], virtual screening [2] and afﬁnity pre-
diction [3]. There have also been a number of recent
publications examining the performance of ligand-based
tools in similar tasks. The ligand-based tools have also
been evaluated in the areas of pose reproduction (by con-
former generators [4–6]), virtual screening [7] and afﬁnity
prediction [8]. In the following sections some issues with
studies on pose prediction and virtual screening will be
discussed.
Pose prediction
A common method of evaluating a docking program is to
gauge its performance in cognate re-docking or self-
docking. In this process a ligand is extracted from a co-
crystal structure with its target protein and the program is
challenged to pose the ligand as closely as possible to its
experimentally identiﬁed structure. It may be argued that
cognate re-docking is not a task commonly faced in the
normal use of docking tools, since cross-docking (docking
of a ligand into a structure with which it was not crystal-
lised) is the actual application of a docking tool [9].
However, the exercise remains popular, doubtless in part
due to the relative ease of execution of a self-docking study
and partly for comparison with previous studies. As has
been pointed out previously [10], comparing docking pro-
grams for their ability to predict the bioactive pose of a
ligand is difﬁcult for a number of reasons, some of which
are obvious while others are subtler. However, the
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way should not cause other sources of error to be ignored.
It is a truism that it is meaningless to compute a property
with greater precision than the accuracy of the experiment
that measures that property. Unfortunately, as will be seen
in subsequent sections, this is often ignored by authors of
papers in the area of pose prediction.
When comparing tools for pose prediction, the heavy
atom root mean square deviation (RMSD) between the
computed and experimental poses is the de facto standard.
A regrettably common method to compare docking tools
for pose prediction success––illustrated, for example, in the
papers presenting results from the MolDock program [11]
or the Glide XP evaluation [8]––is to compare the average
RMSDs across a set of structures. The use of the average
RMSD admits of many possible problems of interpretation,
not least of which is the biasing of the average by a few
very large or very small numbers. In the case of the Mol-
Dock results, the mean RMSD across a set of structures
was used to suggest that the performance of MolDock was
comparable to that of GLIDE and superior to that of Sur-
ﬂex (see Table 1). However, the use of the median RMSD,
which is far less biased by a few extrema, suggests a dif-
ferent conclusion—that MolDock is in fact somewhat
superior to Surﬂex, but not as good as GLIDE. For a
similar analysis on the drawbacks of using average RMSD
as a comparator, see Cole et al. [10]. A number that is
noticeably absent from this, and all other comparisons of
docking tools using RMSD, is an error bar on the average
RMSD (which can be calculated by bootstrapping). With-
out such an error bar it is impossible to assert that any tool
compared in this study is actually better than any other.
A separate issue with these two experiments involves
contamination of the dataset used to evaluate the perfor-
mance of the tools. In the case of the Glide results the
RMSD’s given are not to the deposited crystallographic
pose but rather to one that results from a pre-processing
step, as noted by the authors of the MolDock paper [11]. As
such this is not an ‘‘apples to apples’’ comparison, since the
Glide pre-processing step optimizes protein and ligand
coordinates using the force-ﬁeld component of the Glide
scoring function, which necessarily introduces bias in the
structure. In the MolDock case the authors have essentially
trained the MolDock ﬁtness function on the 77 complexes
that they use to evaluate its performance. As such the
reported results give no indication of the likelihood of
success in predicting a pose for a system upon which
MolDock was not trained.
The RMSD between two poses is a geometric measure,
comparing the atomic positions between the experimental
structure and the docked or predicted structure. Other
metrics based on comparing the geometry of the experi-
mental and the computed pose have been developed, such as
relative displacement error (RDE) [12]. These, and all other
atom-based metrics, suffer from the drawbacks pointed out
by Cole et al. [10]. A more serious problem for metrics like
RMSD and RDE is that they attempt to indicate the quality
of reproduction of a model for the data, not the crystallo-
graphic data itself, i.e., the electron density. This
disconnection between RMSD as a metric of quality for
pose prediction and the original crystallographic data has
been a cause for concern. Some attempts have been made to
arrive at metrics that better reﬂect the reproduction of the
actual crystallographic data, in particular real-space
reﬁnement (RSR) [13]. Unfortunately, RSR has not been
widely used, possibly because it is more difﬁcult to calcu-
late than atom-based metrics like RMSD or RDE. Other
metrics that are not based purely on atom position, such as
interaction-based accuracy classiﬁcation (IBAC) [14], try to
reﬂect the ultimate use of the predicted pose, i.e., deter-
mining the nature of the interactions that the ligand makes
with the protein. While the IBAC approach has value in that
it assesses a computed pose by its interactions with the
protein, it is not amenable to automation; it is therefore
tedious to assemble sufﬁcient data to make statistically
robust comparisons between tools based on IBAC.
However, the problem of choosing which metric to use
to compare pose prediction studies is dwarfed by the dif-
ﬁculty in choosing a dataset of protein–ligand co-
complexes upon which to perform the comparison. A
widespread tendency in conformer reproduction and pose
prediction studies is to ignore even the possibility of error
in the crystal structures that are being reproduced. Crystal
structures are often treated as perfect, inﬁnitely precise and
accurate representations of the atomic details of a protein–
ligand complex. There are a number of reasons why this is
not so; a few will be discussed in the following paragraphs.
Crystal structures are models
This statement makes up the warp and weft of crystallog-
raphy, yet in the transition of crystallographic data from
crystallographer to computational chemist the distinction
between the actual data and a model for that data is often
lost. The actual data in crystallography is, of course, dif-
fraction data leading to electron density. The atom
Table 1 Comparison of RMSD results from a set of docking engines
MolDock GLIDE Surﬂex
Mean 1.38 1.38 1.86
SD 1.49 1.74 2.02
Median 0.92 0.69 1.10
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123positions that make up a crystal structure are a model that
attempts to explain this data in as complete a fashion as
possible. This is illustrated in Fig. 1.
The process of ﬁtting or modeling the atoms (of a ligand
or of a protein) into the electron density is not always
straightforward, and the problems are often more serious
when the ﬁtting of a ligand into density is being carried out.
The sources of these problems include:
(i) Incomplete or fragmentary density;
(ii) The electron density not deﬁning the positions of all
atoms unambiguously;
(iii) Poor structural parameters are used for the ﬁtting
process, which can give inappropriate conformations
(particularly of ligands);
(iv) Errors by the users, arising from careless treatment of
the data or lack of expertise with small molecules.
A variety of metrics can be calculated for a given crystal
structure that attempts to give an indication of the quality
of the model. While no single number can encompass the
quality of a structure, some of the metrics of quality are
more useful than others. The most commonly used is the
nominal resolution. This is a measure only of the quantity
(of data collected) and not of the quality of the data nor,
most especially, of the quality of the model ﬁtted to that
data. (For a discussion on the problems with resolution, see
Ref. [15]) It is therefore unfortunate that nominal resolu-
tion is often the only criterion used to select a protein
structure, and that its meaning is often misconstrued. For
example, in a paper [16] by Nissink et al. the following
incorrect statement is made: ‘‘The resolution of a protein
structure is directly related to the accuracy of the data.’’
Not only is this statement not entirely true, it also confuses
what the nominal resolution means (quantity of data col-
lected) with the accuracy of a model, which are two very
different things. A metric that does attempt to assess the
quality of the ﬁt of the crystallographic model to the source
data is the so-called Rfree, introduced by Brunger [17]. Rfree
is an indication of how well an atomic model explains a
small percentage of the density data that was omitted
during the ﬁtting process, and is thus an unbiased metric
that can be reliably used to distinguish a well ﬁtted model
from a poorly ﬁtted model. Unfortunately, Rfree is infre-
quently used as a metric of quality when selecting crystal
structures for docking studies or other purposes (see Ref.
[18] for the use of Rfree as a criterion for selection of
structures). More frequent use of Rfree as one of a set of
metrics for selection of crystal structures could help to
avoid the selection of poorly ﬁtted models for pose
reproduction.
Crystal structures have unavoidable imprecision
As already discussed, nominal resolution is not a metric of
quality for a structure and although Rfree indicates the
quality of the ﬁt of the model to the original data it can
provide no estimate of the uncertainty in the atomic posi-
tions within that model. It is often assumed that the
experimental uncertainty in the atomic positions in a
crystallographic model can be estimated by use of the
isotropic B-factor, which is supposedly a measure of the
thermally driven ﬂuctuation in atomic positions. However
B-factors are a reﬁned parameter and so they cannot be
compared between structures without detailed knowledge
of the restraints used [19]. It is therefore impermissible to
use low B-factors as a sure indication of low positional
uncertainty. Nor is it possible that there exists a uniform
cut-off for B-factors that indicates low positional uncer-
tainty in all structures, though such an assumption is
frequently made [20]. Another potential problem with
B-factors is that they can be over-reﬁned in the pursuit of
better quality metrics for a structure. An example is given
in Fig. 2, which shows the ligand (leucinol) from the
structure 5ER1 from the RCSB [21] annotated with its
B-factors. The B-factors for every atom in the ligand are
\1. In contrast, B-factors even for well-located atoms in
Fig. 1 Fitting atoms into electron density produces a crystallographic
model
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instance the crystallographer has over-reﬁned the B-factors
of the ligand atoms in order to improve the quality of the
overall model. In this model the B-factors are unphysically
low only as a consequence of a pathology of the reﬁnement
process. Accordingly, B-factors as an indication of local
mobility in a protein structure should be treated with cau-
tion, as they are not simply an experimentally derived
quantity but are free parameters in the reﬁnement process.
An alternative to using the average B-factor for esti-
mating the uncertainty of the position of atoms an atom in a
structure is the average coordinate precision (or diffraction-
component precision index, DPI). The DPI expresses the
average precision for the atomic coordinates in a protein
structure [23] and as such can be used as a measure of the
experimental precision of the atomic positions in that
structure. The original formulation of DPI was very com-
plex and has recently been recast in a more easily
calculable way by Blow [24]. The use of DPI as a metric of
quality for crystal structures used for docking studies was
introduced to the computational community by Goto et al.
[18], and their formula is given in Eq. 1
1.
r r, Bavg

¼ 2:2Natoms
1=2Va
1=2nobs
 5=6Rfree ð1Þ
In this treatment the standard error of position, r(r), is
related to the number of atoms in the unit cell, Natoms, the
volume of the unit cell, Va, the number of crystallographic
observations, nobs and the Rfree. It should be noted that the
formula presented by Goto et al. is not precisely the same
formula that Blow derives in his paper. In Eq. 1 the pre-
factor is given as 2.2, while in the original work by Blow
the prefactor is given as 1.28. This is because Blow is
calculating coordinate error for a particular axis, r(x, y,
or z), while Goto et al. are calculating the error in the
distance, r(r), giving rise to the H3 difference between
the two prefactors. As such it is appropriate to consider the
error in the coordinates, r(x, y, z) as a measure of the
uncertainty in the atomic positions, and the error in inter-
atomic distances, r(r), when comparing a computed and an
experimental structure.
The resolution of a crystallographic model, as has been
mentioned, is often used to select protein structures for
pose prediction by docking or conformer generation stud-
ies, on the assumption that resolution imparts some
information on the quality and precision of the model. The
DPI is a much more direct estimate of the reliability of
crystallographic models when it comes to comparing
experimental and computed atom positions (as is done in
conformer reproduction or pose prediction). It is therefore
of interest to compare the nominal resolution for a large
number of ‘‘good quality’’ crystal structures with the DPI
(r(r)) for the same structures. A good dataset for this
comparison is provided by the extensive investigations
performed by Kirchmair et al. [4]. Here 776 co-crystal
structures were used to provide experimental ligand
structures that were then compared to sets of computed
conformations from conformer generation applications. For
556 of these crystal structures there exists sufﬁcient data to
allow the DPI to be calculated and the relationship between
the nominal resolution for these structures and their DPI is
shown in Fig. 3. It is obvious from Fig. 3 that the statement
by Kirchmair that ‘‘0.5 A ˚ approximately represents the
accuracy of protein X-ray crystallography’’ is not sup-
ported by the actual properties of the crystal structures they
studied. In fact, in those cases where the DPI can be cal-
culated, almost 56% of the structures from their paper have
DPIs[0.5 A ˚.
Figure 3 illustrates a number of other interesting points.
While the expectation that greater coordinate precision will
arise from structures with better nominal resolution is
generally borne out by the data, there are many exceptions.
Table 2 shows some examples of structures where the
nominal resolution gives an unexpected estimation of
coordinate precision. In the top half of the table are
Fig. 2 B-factors for the ligand in the 5ER1 crystal structure
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Fig. 3 Coordinate error for 556 structures from the paper by
Kirchmair et al. [4]
1 Goto et al.’s formula to calculate DPI.
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123structures with good nominal resolution but unexpectedly
high DPI, while the lower half of the table shows some
structures with low nominal resolution and either unex-
pectedly low or unexpectedly high DPIs. Accordingly,
simply using nominal resolution as a metric of quality for
structures to be used in a pose prediction or conformer
generation study is insufﬁcient to guarantee that structures
of appropriate quality will be used.
With the DPI for a structure in hand one can set a lower
limit on the precision with which a computed conformation
can reproduce an experimental one—the RMSD between
the two conformations cannot be less than the DPI for the
experimental structure. It can be seen that over half
(55.6%) of the structures in this set has DPIs[0.5 A ˚,
while Kirchmair et al. report pose reproduction statistics
both at\0.1 A ˚ and at\0.5 A ˚ RMSD. Since in over half of
the structures in this dataset the DPI is[0.5 A ˚, Kirchmair
et al. report pose reproductions at\0.5 A ˚ RMSD that are
more precise than the accuracy of the source data allows.
This analysis is made on the conservative assumption that
the error in the atomic positions in the computed pose is
zero. In the Goto et al. paper [18] the assumption is made
that the errors in the computed pose are the same as for the
experimental pose. In this analysis a computed and
experimental pose must be different by an RMSD of
H2 9 DPI for the difference to be signiﬁcant, which would
mean that an even higher proportion of the poses in the
Kirchmair set have been reproduced with a greater preci-
sion than the experimental accuracy.
The same tendency to reproduce experimental data with
a precision greater than the experimental accuracy is seen
frequently in pose prediction experiments with docking
engines. In Fig. 4 nominal resolution is plotted against the
DPI for crystal structures from two well known docking
validation sets, those for GOLD [25] and GLIDE [3]. The
two graphs are plotted on the same scale to allow direct
comparison. On each graph is also plotted an estimate of
the theoretical lower limit for the atomic precision (the
pink line). A formula describing the relationship between
nominal resolution and DPI is given in Eq. 2
2 below, based
on a derivation by Blow [24].
r r, Bavg

¼ 0:22 1 þ s ðÞ
1=2VM
 1=2C 5=6Rfreedmin
5=2 ð2Þ
The variables found in Eq. 2 are as follows: s is the
percent solvent present in the crystal, Vm is the asymmetric
unit volume to molecular weight ratio, C is the complete-
ness of the data, and dmin is the nominal resolution of the
structure. The ideal lines shown in Fig. 4 were calculated
using Eq. 2 and assuming an s of 0.0, a Vm of 2.5, a C of
100%, and that Rfree is equal to the resolution/10.
Inspection of Fig. 4 shows that the GOLD set contains
one structure (1YEE) whose calculated DPI lies below the
theoretical lower limit. This is probably due to a mistran-
scription error in the PDB ﬁle. The PDB ﬁle for the 1YEE
structure gives the number of reﬂections as 77209, while
the number of unique reﬂections is 21342—a disparity that
Table 2 Resolution and DPI for selected structures from the Kir-
chmair dataset
PDB code Resolution (A ˚) DPI (A ˚)
1FC7 1.38 0.69
1FDO 1.38 0.60
1JJT 1.8 1.37
1JJE 1.8 1.25
1CIB 2.5 5.54
1ILH 2.76 0.14
1C8M 2.8 0.18
1QJX 2.8 0.25
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Fig. 4 The nominal resolution versus the coordinate error for a
subset of the Gold (structures with resolution\2.5 A ˚) and the Glide
data sets
2 Blow’s derivation for the relationship between nominal resolution
and atomic precision using the Goto et al. [18] coefﬁcient.
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123cannot be reconciled by reference to the data redundancy
for this structure. Accordingly the calculated DPI for 1YEE
is too low because the reported number of reﬂections is
erroneously high. In the GLIDE set all structures have DPIs
higher than our predicted theoretical minimum. In fact, in
this set 52% of the structures have a DPI[0.5 A ˚, and in
31% of the cases the reported RMSD for redocking is less
than the DPI (so that the prediction is more precise than
experimental accuracy allows). This is only one example of
a publication in which protein structures are assumed to be
free of uncertainty in their atomic positions; the literature
abounds with others.
The combination of Rfree and the DPI for a structure can
give a good overall picture of the quality of a model and
the reliability of the atom positions within that model. In
spite of the availability of these and other measures of
quality, there are a number of test sets of protein co-crystal
structures used for evaluating docking engines that appear
to have been selected by other criteria that do not relate in
any way to their quality [26]. Accordingly, the results from
these studies should be treated with some caution.
Crystal structures have avoidable errors
The Rfree and the DPI are global measures of quality; other,
local, measures of quality are also useful. For example, if a
small portion of the atoms in a structure have been poorly
ﬁtted to the density, this will not be revealed by any global
measure of ﬁt. Only a local measure would reveal the error.
A relatively common problem in co-crystal structures in
the PDB is poor ﬁtting of small molecules to the density,
giving unrealistic ligand structures. These poorly ﬁtted
ligand structures are then used as a ‘‘standard’’ to judge the
quality of a docking program’s or conformer generator’s
performance. While the poor quality of some ligand
structures in PDB models has been known for some time
[27], these reports have been anecdotal and few systematic
attempts to avoid such poorly solved structures (other than
visual inspection) appear to have been undertaken. If
appropriate attention is not paid to selecting good quality
ligand structures, then a dataset could be constructed that
contains ligand structures that have signiﬁcant errors. For
pose prediction studies, poorly solved ligand structures in
the dataset must be avoided. It is senseless to try to com-
putationally reproduce an ‘‘experimental’’ ligand structure
that has been incorrectly ﬁtted to the electron density.
Examples of some possible errors in ligand structures that
should result in structures that are not computationally
reproducible are shown in Figs. 5 and 6.
In the case of the 1A8T structure (Fig. 5), the deposited
ligand coordinates contain two serious atom–atom clashes
that give the resulting conformation very high energy
(28.4 kcal/mol above a reﬁtted structure by the MMFF94
forceﬁeld [28]). The deposited coordinates are clearly in
error in this case and no docking engine or conformer
generator should be expected to reproduce such a structure.
The error shown in Fig. 6 for the 1A4k structure is of a
more subtle nature. Here the crystallographer has ﬁtted a
highly strained cis-amide into the electron density with no
compelling reason from the electron density to do so. The
amide group is packing against a tyrosine residue from a
symmetry mate in the unit cell, and makes no polar inter-
action with it. The corresponding trans-amide, which ﬁts
the experimental density just as well, is 15.5 kcal/mol
lower in energy (using the MMFF94 force-ﬁeld). Also this
trans amide is able to make a hydrogen bond (with a
backbone carbonyl group) that is not available to the cis
conformation. Once again, this model should not be
reproduced by a docking engine or conformer generator, as
it is obviously not the correct solution.
One of the only studies that bears on the issue of ligand
strain was published by Perola and Charifson in 2004 [29].
The authors examined ligand strain in a number of public
structures from the RCSB database and proprietary
Fig. 5 Ligand conformation from 1A8T structure. The conformation
has two serious atom–atom clashes
Fig. 6 Ligand conformation from the 1A4K structure. The cis-amide
group is an error of ﬁtting
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10% of the ligand structures examined had high strain
(10 kcal/mol or greater above the global minimum). The
two examples discussed above, 1A8T and 1A4K, are both
part of the Perola dataset. Clearly these two ligand struc-
tures have high strain energies due to errors in ﬁtting and
not due to a fundamental property of the ligand’s confor-
mation in complex with the protein. Close examination of
the rest of the models for the ligands (where structure
factors are available) showed that a number of them are
incorrect, and re-solving them provided lower energy
structures in about 85% of the cases [30]. Recent re-
examination of the Perola dataset by the Snyder group has
provided further insights into the large strain energies
originally reported [31]. It is therefore most likely that the
vast majority of ligand conformations in complex with a
protein show strain energies less than 6 kcal/mol, unless
the ligand is rather large [32]. Those ligand conformations
with strain energies higher than 10 kcal/mol are almost
certainly incorrect. As such low ligand strain should be
among the criteria for selection of structures for pose
prediction, as structures with high strain are very likely to
arise from errors in the ﬁtting process.
It is clear from the foregoing discussion that, while
crystal structures are an invaluable source of information
on protein–ligand binding, these structures are not without
many sources of confounding errors. These errors, those
inherent to the data and the process of ﬁtting, as well as
those introduced by human error or the insufﬁciencies of
the ﬁtting program, should be borne in mind before using
crystal structure data. The selection of a reliable set of
structures for pose prediction is a therefore not a trivial
task. An excellent study considering these issues can be
found in Hartshorn et al. [33].
Virtual screening
Virtual screening can be deﬁned as any method that ranks a
set of compounds by some score. Successful virtual
screening relies on having a scoring method that assigns
good scores to interesting molecules (usually deﬁned as
active against a target protein of interest) and worse scores
to uninteresting (inactive) molecules. Accordingly a suc-
cessful virtual screen will provide, from the top of this
ranked list, a set of compounds for experimental screening
that is highly enriched in active molecules. This topic has
been of great interest both in academia and in the phar-
maceutical industry in recent years, and a large number of
publications have appeared on the subject. While a few of
the publications have investigated virtual screening con-
ducted prospectively [34–36], the vast majority have been
concentrated in the area of retrospective virtual screening.
In the rest of this article we shall concern ourselves solely
with the retrospective experiments. The goal of such
experiments is often to identify an application that per-
forms well on a given target, or across a wide range of
targets, with a view to utilizing this application in pro-
spective virtual screens.
There are a number of approaches to quantitating the
success of a particular tool for virtual screening. The most
often used, and simplest to calculate, is enrichment at a
given percentage of the database screened. Enrichment
(EF) is deﬁned according to Eq. 3
3 (Hitssampled
x% = number
of hits found at x% of the database screened, Nsam-
pled
x% = number of compounds screened at x% of the
database, Hitstotal = number of actives in entire database,
Ntotal = number of compounds in entire database).
EF ¼ð Hitssampled
x%=Nsampled
x%Þ (Ntotal/Hitstotal) ð3Þ
Enrichment appears to measure the quantity of most
interest to those performing virtual screening: the ability of
a tool to place a large proportion of the active compounds
at the top of the ranked list. Enrichment is also simple to
calculate and understand, so it seems the ideal metric with
which to compare tools for their virtual screening perfor-
mance. However, enrichment suffers from a number of
signiﬁcant drawbacks, especially when comparing results
between studies or using enrichment to predict future
performance:
(i) It is dependent on the structure of the dataset, in that
datasets with larger proportions of actives will have a
narrower range of possible enrichments.
(ii) It penalizes ranking one active compound above
another.
(iii) It exhibits pernicious behaviour at the cut-off at
which the enrichment is calculated.
(iv) It gives no weight to where in the ranked list a known
active compound appears. Thus to calculate enrich-
ment at 1% in a virtual screen of 10,000 compounds,
the number of actives (N) in the top ranked 100
compounds is needed. However the enrichment at
1% is the same whether the N active compounds are
ranked at the very top of the list or at the very bottom
of the top ranked 100.
(v) It is difﬁcult to calculate analytically errors in
enrichment, and there is no available literature for
such a calculation.
With regard to point (i), experiments performed on
different datasets cannot be compared when using enrich-
ment, as the dynamic range of enrichment will be different
for different datasets, but there are several cases where this
has been done [37]. Early enrichment can also suggest
3 Enrichment calculation.
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fraction of the active molecules very early in the list, but
fail to give good ranks to the majority of the actives [37]. It
has been shown by Seifert [38] that enrichment does not
detect signiﬁcant pathologies in the ranking function. Other
metrics have been developed by some groups speciﬁcally
to address some of these problems: RIE by Merck [39],
cumulative probability by Molsoft [40] and average num-
ber of outranking decoys by Schrodinger [3]. These metrics
have, historically, only been used by the groups that
invented them and are thus not useful for comparison to
studies conducted by other groups. This lack of direct
comparability across studies is compounded by the fact that
these metrics cannot be converted into a more commonly
used metric that could be used to compare results. Also, as
with enrichment, it is unknown how to estimate analyti-
cally errors in any of these metrics.
A metric used to determine success in detecting a signal
in a background of noise is the receiver operator charac-
teristic (ROC). The ROC curve is derived by plotting noise
(fraction of false positives) on the x-axis versus signal
(fraction of true positives) on the y-axis. The area under the
ROC curve (AUC) is a widely used measure in a variety of
ﬁelds including medical statistics, criminology and bioin-
formatics [41, 42]. When applied to virtual screening the
ROC illustrates success in ranking actives (signal) above
decoys (noise). The AUC for the ROC curve shows per-
formance of a given tool when screening across the entire
database is examined, not just at ﬁxed, early points in the
screen as enrichment does. The theoretically perfect per-
formance of a virtual screening application gives the
maximum area under a ROC curve (1.0), while random
performance of a tool gives an AUC of 0.5. Areas under the
curve of less than 0.5 imply a systematic ranking of decoys
higher than known actives. For recent applications of the
ROC curve in virtual screening, see [2, 43]. The AUC for
the ROC curve is also known as the ‘discrimination’.
Discrimination is deﬁned as the fraction of occurrences that
a randomly chosen true positive (active) is given a better
score than a randomly chosen true negative (decoy). This
number then allows prediction of the likely effectiveness of
a tool in experiments that have not yet been conducted.
This predictive ability is not provided by metrics such as
enrichment, cumulative probability and average number of
outranking decoys, because while the ROC describes a
property of the application studied, the other metrics
essentially describe a property of the experiment. The AUC
assesses virtual screening performance across the entire
database and many practitioners of virtual screening are,
rightly, most concerned about early performance of the
tools they use. This is one reason why enrichment is so
commonly used to measure success. The metric of early
performance based on the ROC curve is the true positive
rate at ﬁxed false positive rates. The true positive rate at a
false positive rate of, for example, 1% is a much more
robust measure than the enrichment at 1% and provides
similar information about the early performance of a tool.
The AUC also offers the advantage that a statistically
robust estimate of its errors can be estimated analytically
from the AUC itself, using a method developed by Hanley
[41]. This is not a property possessed by enrichment,
average number of outranking decoys etc. For these metrics
errors can only be estimated (by bootstrapping or other
approaches) from the raw data, which is rarely provided.
The error in the AUC, as with other metrics, is reduced by
increasing the number of positives (active compounds) and
by increasing the number of negatives (inactives). The
Hanley treatment shows that the error in the AUC is most
signiﬁcantly reduced by increasing the number of actives,
while increasing the number of decoys has a much smaller
impact on the error. Therefore virtual screening datasets
with high proportions of active compounds will provide
results with lower error bars for the AUC. With the error
for an AUC available, meaningful comparisons can be
made between two or more different tools. However the
other metrics used for virtual screening mentioned above
do not allow an analytical estimation of their errors.
Comparisons designed to determine which tool is superior
for a given purpose, that are based on metrics assumed to
be free of errors, are fraught with difﬁculty.
While the choice of metric may affect the relative
ranking of tools compared on the same datasets, the com-
position of those datasets has a very profound effect on the
results generated. Until very recently it has been common
practice to assemble a dataset for virtual screening by
seeding a set of active molecules against a target of interest
into a background of compounds (decoys) chosen essen-
tially at random. These decoys compounds were often
drawn from public sources such as vendor catalogues. An
example of this approach is the seminal paper on virtual
screening by docking from the Rognan lab where decoy
compounds were selected at random from the publicly
available compounds [44]. This set of decoys, or a subset
thereof, has been used extensively since its publication in
2000 [2 and references therein] so that this same set of
decoy compounds has been used in more than 45 different
published virtual screening experiments on a wide variety
of target systems. Given the huge variety in the types of
active molecules camouﬂaged in this same set of decoys it
seems intuitively obvious that in some cases the active
compounds for a given target will be very easily discrimi-
nated from these decoys. As such a number of the virtual
screening experiments performed using this set of decoy
compounds have given good results purely due to differ-
ences in simple properties between the actives and the
decoys (vide infra). In the Rognan dataset there were
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12310 active compounds for each of the targets studied and 990
randomly selected decoys. There are two problems arising
from constructing a dataset in this way. The ﬁrst is that the
small number of active compounds means that the errors
can be very high (vide supra). The second is that trivial
property differences between the active compounds and the
decoys can result in undeservedly good performance. The
ﬁrst issue, low prevalence, is still widespread in retrospec-
tive virtual screening studies. Although low prevalence
reduces the reliability of the results, many virtual screening
experiments are still conducted using very low numbers of
active compounds. Reasons for this could include a desire to
mimic ‘‘real’’ HTS experiments, where hit rates are often on
the order of 0.01–0.1% [45] or to allow enrichment, the
most commonly used metric for success in these studies,
the maximal dynamic range. Tribelleau et al. [43] show that
the dynamic range of enrichment, the difference between
random and maximal performance, decreases as the pro-
portion of active molecules in a dataset rises. For a recent
example of a retrospective virtual screening study with
deliberately large numbers of actives, providing high sta-
tistical power and small error bars, see Ref. [37].
The second issue, systematic differences in simple prop-
erties between decoys and actives in retrospective virtual
screening experiments, is much more serious. As has been
pointed out in a number of publications, scoring functions in
docking programs, which are almost always additive, are
sensitive to molecular size or heavy atom count, the number
of hydrogen bonds that the molecule can make etc.
Accordingly, systematic differences in these simple molec-
ular properties between actives and decoys will cause
systematic differences in ranking. For example, active
compoundswithhigheraverageheavyatomcountswilltend
torank better than the decoys whenscored by a function that
is sensitive to heavy atom count. For a fuller discussion of
this issue see Verdonk et al. [46]. An example of the inﬂu-
enceoftheselectionmethodsfordecoysonvirtualscreening
performance is shown in Fig. 7. In this ﬁgure, two retro-
spective virtual screening studies against CDK-2 using the
dockingtoolFRED[47]arecomparedusing ROCcurves.In
bothcasesthesameactivesweredockedagainstthesameco-
crystal structure, while different decoy compounds were
used. In one case (the green line), the decoys were chosen at
random from the Maybridge compound collection [48], in
the other (the red line), decoys were chosen to match the
properties of the actives based on simple 1D properties. The
striking difference, especially in early performance, is
obvious. Clearly the performance of FRED is heavily
affectedbythenatureofthedecoycompounds,andtoobtain
a predictive indication of the utility of FRED in virtual
screening decoy sets similar to those giving the red line
should be used. It is worthy of note that the AUC’s for the
two experiments shown are different by more than their
respective95%conﬁdenceintervals,sothatthisdifferenceis
indeed statistically signiﬁcant.
Another example of how much of the signal that separates
active from inactive compounds arises from systematic dif-
ferences between their properties is shown in Fig. 8.I nt h e s e
eight examples, drawn from the Surﬂex-Dock dataset [2], the
performance ofthree 3Dvirtualscreeningmethods––Surﬂex-
Dock, ROCS [49] and FRED––is compared to a simple 1D
method. In this 1D approach [46, 50], compounds are ranked
bydistanceinanEuclideanpropertyspacetothecentreofthe
space deﬁned by the active compounds. The Euclidean space
is deﬁned by ﬁve simple molecular properties: number of
donors, number of acceptors, number of rotatable bonds,
XlogPand0.01 9 molecularweight.Thisconceptofranking
compounds by distance in a high dimensional Euclidean
property space has recently been published as a virtual
screening method, known as DACCS [51].
It is clear from Fig. 8 that in four of the eight cases
(OPPA, HIV-PR, TK and PARP) the active compounds are
very dissimilar from the background set, as the 1D ranking
method gives very good virtual screening performance. In a
ﬁfth case (TS) the performance of 1D method is as good as
any of the 3D methods, although none of the tools perform
particularly well. Accordingly, judging virtual screening
Fig. 7 Effect of decoy selection method on virtual screening by
docking
1D v. 3D methods  
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Fig. 8 AUCs for various virtual screening methods on part of the
Surﬂex-Dock validation set
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123performance for any tool using such datasets is unlikely to
be productive as most of the ‘‘signal’’ separating actives
from decoys lies purely in differences in simple molecular
properties. A further confounding issue with these datasets
is that a large number of the active compounds in these sets
are close structural analogues of one another. For ligand-
based methods this high structural similarity amongst the
actives can cause the actives to be very easily discrimi-
nated from the decoys, while a structure-based method may
have more difﬁculty. Accordingly, while property bias is
an important consideration in constructing decoy sets,
analogue bias should be carefully considered when
selecting sets of active compounds.
A recent effort to avoid some pathologies arising from
poorlyselecteddecoysetshascomefromtheworkofHuang
et al. [52] with the Database of Useful Decoys, or DUD. In
this work decoys were selected to match the same simple
molecular properties of the active compounds using a sim-
ilarapproachtothatmentionedearlier,sothatthedecoysare
not trivially separable from the actives. DUD represents a
very wide-ranging dataset (actives against 40 target pro-
teins) that has been designed to evaluate the underlying
performance of docking tools, and not the sensitivity of that
tool’s scoring metric to differences in simple molecular
properties.NotethattheDUDdecoyselectionapproachuses
a discontinuous representation of the molecular properties,
while the approach mentioned above uses a continuous
representation.Thesimilaritybetweenthesetwoapproaches
for decoy selection and the DACCS approach for active
selection is striking. It is a topic of further investigation
whethermuchofthereportedsuccessoftheDACCSmethod
is due to over-training/poor active compound selection.
The work of Huang et al. with the DUD dataset showed
that, at least for DOCK, this approach of speciﬁcally
matching the properties of the decoys to those of the actives
can produce more difﬁcult decoy sets than those chosen
purely for drug-likeness in a number of cases. It should be
noted that the differences in performance reported in the
DUD paper are essentially anecdotal, since no error bars are
reported.WiththatcaveatinmindinspectionofFig. 4ofthe
DUDpaper,inwhichcomparisonsofperformanceofDOCK
between the DUD ‘‘own’’ decoy sets and some commonly
available agnostic decoys are shown, is instructive. In 10 of
the12casespresentedtheDUD‘‘own’’decoy setisthemost
challenging ofthefour decoy setscompared,implyingthata
property-matched decoy set can provide a more difﬁcult
backgroundsetthanan‘‘agnostic’’orgeneraldecoyset.Fora
drug-like decoy set chosen without speciﬁc reference to the
active compounds being screened for, which is therefore to
be expected to be less challenging than decoy sets designed
with speciﬁc reference to the actives being searched for, see
Ref [53]. The DUD datasets also have relatively high prev-
alence (the design goal was to achieve a prevalence close to
3%, though this varies slightly from target to target), giving
the results generated with DUD reasonably low errors
(exceptforthosecaseswherethenumberofactivesissmall).
This is not to say that DUD is perfectly constructed––there
are still some large differences between the properties of the
activesandthe decoys insomecasesandinsomecasesthere
are so few active molecules that statistically robust results
cannot be generated. An important property not considered
intheselectionoftheDUDdecoysisformalcharge.Assuch,
there are some sets of the DUD actives that are easily dis-
criminated from the decoys based on formal charge. For
example, the mean formal charge on the neuraminidase
ligands is +1.76, while the mean charge on the decoys is
+0.76. For acetylcholinesterase, the mean charge on the
actives is -1.68, while the mean charge on the decoys is -
0.76. As with the datasets illustrated in Fig. 8, the DUD
activesetswerenotchosenwithaviewtostructuraldiversity
and some of the active sets consist entirely of closely anal-
ogous compounds. Very recently the original DUD dataset
hasbeen extended byaddingmoreactivecompoundsandby
clustering the actives to remove trivially graph similar
actives from the set [54]. This makes ‘‘DUD 2.0’’ a suitable
dataset not only for docking approaches but also ligand-
basedtechniques.Itshouldbenotedthatthereisalimittothe
acceptable level of similarity between actives and pre-
sumptive decoys. When the decoys are too similar to the
actives the assumption that the decoys are inactive becomes
increasinglyuntenable,givingrisetolargenumbersof‘‘false
falsepositives’’.Accordinglytheproblemofdecoyselection
is not yet completely solved, and may not admit of a single
solution for all problems or tools. However, since in retro-
spective work the point is purely to gain a measure of the
expectation of performance in as yet unperformed studies,
the use of carefully designed decoy sets is mandatory.
It is unfortunate that the docking targets in DUD (39
crystal structures and 1 homology model) were not selected
with as much care as the small molecule datasets. In 6 of
the 38 co-crystal structures in DUD (there is one apo
structure in the set), the DPIs are 1.5 A ˚ or more, resulting
in signiﬁcant uncertainty in the positioning of any atom in
these structures. These structures are ALR2 (1AH3), COX-
2 (1CX2), EGFR (1M17), GR (1M2XZ), InhA (1P44) and
p38 (1KV2). Accordingly docking results from these
structures should be interpreted with great care.
Conclusions
Large numbers of evaluations and comparisons of tools for
pose prediction and virtual screening have been published in
recent years, an indication of signiﬁcant interest in identify-
ing tools that will have robust performance in one or both of
these areas. Unfortunately the vast majority of these studies
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123have been invalidated by poor choice of datasets, lack of
considerationoferrorinsourcedataanduseofmetricsthatdo
notpermitrobustcomparisons.Forthosepapersusingcrystal
structure data, too little account is taken both of the
unavoidable imprecision in these structures and of the errors
of ﬁtting that are regrettably frequently seen in structures in
the RCSB. In many cases nominal resolution, a measure of
the quantity of data gathered, is confused with a measure of
quality for the structure and other metrics indicating quality
and reliability (DPI and Rfree) are ignored. When performing
pose prediction geometric measures such as RMSD are
almost always used to compare the experimental and pre-
dicted pose. These measures are uniformly used without
taking into account either the inevitable imprecision in the
atomic positions in crystal structures or the fact that using
geometric measures necessarily implies comparing a model
for the source data with a computed pose. In almost no cases
are crystal structures inspected for errors in ﬁtting. Without
takingallthesesourcesoferrorintoaccounttheresultsofany
publicationthatusescrystalstructuredatawillbesuspectand
oflittleuseindecidingwhattoolsarethemostsuitableforthe
taskathand.Inpapersconcernedwithvirtualscreeningthere
has been, until recently, too little focus on eliminating trivial
reasons for good performance from a given tool. The DUD
dataset [52] hasillustrated ways in which challenging virtual
screeningdatasetscanbeconstructedand, sinceit ispublicly
available, DUD offers the opportunity for a common
benchmark upon which a wide variety of tools can be com-
pared. The plethora of metrics used to judge and compare
virtual screening performance serves merely to confuse the
ﬁeld rather then to clarify it. The lack of conﬁdence intervals
on metrics for success makes meaningful comparisons
between tools almost impossible to interpret. The AUC for
ROCoffersgreatpromiseasametricforvirtualscreening,as
it offers the possibility of predictive value along with robust
errors.ForanexemplaryuseofROCinvirtualscreeningtests
see a recent paper by Jain [55]. It is hoped that the ﬁeld will
soon converge to a single metric of virtual screening perfor-
mance, such as the ROC, that will allow robust and direct
comparisons between tools and between studies.
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